Goodwill of Akari Therapeutics Plc from 18 Sep 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Akari Therapeutics Plc quarterly Goodwill in USD history and change rate from 18 Sep 2015 to 30 Sep 2025.
  • Akari Therapeutics Plc Goodwill for the quarter ending 30 Sep 2025 was $8,430,000.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)

Akari Therapeutics Plc Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $8,430,000 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $8,430,000 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $8,430,000 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $8,430,000 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2015 $19,283,280 18 Sep 2015 20-F 18 Jul 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.